InterCure Ltd. (INCR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.86
-4.00%
Mkt Cap $44.84M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2025 Apr 29, 2025 | — | $15.52M | — | — | -$0.22 | — | — | — |
| Q4 2024 Oct 3, 2024 | — | $14.88M | — | — | $0.03 | — | — | — |
| Q3 2024 Aug 30, 2024 | — | $16.69M | — | — | $0.00 | — | — | — |
| Q2 2024 May 1, 2024 | $101.58M | $17.04M | -83.23% | — | $0.00 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | $20.35M | — | — | $0.05 | — | — | — |
| Q4 2023 Dec 26, 2023 | — | $19.13M | — | — | $0.05 | — | — | — |
| Q3 2023 Aug 31, 2023 | — | $27.73M | — | $0.05 | $0.03 | -40.00% | — | — |
| Q2 2023 May 15, 2023 | — | $29.59M | — | $0.08 | $0.01 | -87.50% | — | — |
| Q1 2023 Mar 31, 2023 | — | $30.62M | — | — | $0.05 | — | — | — |
| Q4 2022 Nov 15, 2022 | — | $28.34M | — | $0.32 | $0.05 | -84.38% | — | — |
| Q3 2022 Aug 15, 2022 | $99.42M | $27.28M | -72.56% | $0.26 | $0.10 | -61.54% | — | — |
| Q2 2022 May 16, 2022 | $87.23M | $27.26M | -68.75% | $0.24 | $0.11 | -54.17% | — | — |
| Q2 2022 Apr 6, 2022 | — | $25.61M | — | $0.14 | -$0.02 | -114.29% | — | — |
| Q4 2021 Nov 15, 2021 | — | $19.13M | — | $0.15 | -$0.01 | -106.67% | — | — |
| Q3 2021 Aug 16, 2021 | — | $13.84M | — | $0.14 | $0.12 | -14.29% | — | — |
| Q2 2021 May 10, 2021 | — | $9.91M | — | — | $0.04 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $8.41M | — | — | $0.11 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $6.55M | — | — | $0.01 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $3.24M | — | — | -$0.01 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $1.18M | — | — | -$0.54 | — | — | — |